Cite
MLA Citation
Harry G M Heijerman et al.. “Efficacy and safety of the elexacaftor plus tezacaftor plus ivacaftor combination regimen in people with cystic fibrosis homozygous for the F508del mutation: a double-blind, randomised, phase 3 trial.” Lancet, vol. 394, no. 10212, 2019, pp. 1940–1948. http://access.bl.uk/ark:/81055/vdc_100137298799.0x00004d